Esketamine Nasal spray
New Treatment / Nasal spray as an adjunctive treatment for depression
The US Food and Drug Administration (FDA) has approved a nasal spray for treatment-resistant major depressive disorder in adults. Esketamine is a chemical mirror image of ketamine. It must be taken with an oral antidepressant.
March 10, 2019
Nasal spray as an adjunctive treatment for depression
The US Food and Drug Administration (FDA) has approved a nasal spray for treatment-resistant major depressive disorder in adults. Esketamine is a chemical mirror image of ketamine. It must be taken with an oral antidepressant.
X